WHO may drop ‘counterfeit’ from its substandard drugs definition; move won't affect national legislation
The World Health Organisation is considering a recommendation that it drops use of the term ‘counterfeit’ when referring to drugs and other medical products that appear to fail regulatory standards and lack relevant approvals.
To read more
Register for limited access
Register to receive our weekly newsletter and access two of our subscriber-only articles per month.
Subscribe and start reading now
Subscribe for unlimited access to articles, in-depth analysis and research from the WTR experts.